Navigation Links
WomanCare Global to Distribute Mifepristone in Europe and Africa
Date:2/9/2012

LONDON, Feb. 9, 2012 /PRNewswire-USNewswire/ -- WomanCare Global announced today that mifepristone has been added to their reproductive healthcare portfolio.  Through an agreement with Linepharma, WomanCare Global will provide sales, marketing, provider training and distribution of mifepristone in seven European and seven African countries. 

(Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO )

Linepharma's mifepristone is labeled for use as a single 200mg tablet of mifepristone to perform medical abortion in conjunction with a prostaglandin, in compliance with the World Health Organization's recommendation. Linepharma's mifepristone is manufactured in Europe and is currently approved in five E.U. countries.

The planned distribution of mifepristone by WomanCare Global in 14 countries will ensure that close to 55 million women will have another safe, quality product to manage their reproductive health.  

"To date, a European-approved mifepristone has only been available in a limited geographic area," said WomanCare Global CEO Saundra Pelletier. "Providing access to quality reproductive health supplies ensures that women can choose if and when to have children.  This is a critical factor in helping women live to their fullest potential."

"Teaming with WomanCare Global is an achievement for Linepharma which has been built with the aim to bring products approved by the most demanding regulatory agencies and to provide not-for-profit organizations with pharmaceutical support in order to allow women in developing countries to get access to high-quality medicines" said Linepharma General Manager Thomas Kozminski.

"In our many years of working in women's reproductive health, we are very aware of the unmet need for higher quality products. We are so pleased that WomanCare Global is able to provide a solution and make an EU-manufactured mifepristone available to the women we serve," said Ipas CEO Liz Maguire.  "Ipas will work very closely with WomanCare Global on expanding access to mifepristone in Africa.  Bringing this life saving technology to women in low-resource settings is critical to reducing deaths and injuries from unsafe abortion and helping women make their own reproductive decisions."

About WomanCare Global
WomanCare Global is a nonprofit organization working with partners around the world to improve the lives of women by providing access to affordable, quality reproductive health products. The organization believes that every woman, no matter where she lives, should have control over her reproductive health and family planning needs, ultimately improving her ability to care for herself and her family. WomanCare Global closes the access gap by bringing the same quality products available in the developed world to developing countries. WomanCare Global serves both public and private sectors via an established global supply chain reaching countries around the world, with particular focus on under-served markets in Africa, Asia and Latin America. WomanCare Global was established by Ipas in 2009 and the two organizations continue to work closely together.  WomanCare Global operates independently as a UK Registered Charity (No. 1138896).  For more information, please visit womancareglobal.org

About Linepharma
Linepharma is a European pharmaceutical company which identifies, develops and registers medicines or medical devices which offer health benefits to women and need specific approaches for commercialization. Currently, the company is focused to make medical abortion safe and affordable and to develop medicines for the treatment and prevention of ob/gyn conditions such as post-partum haemorrhage. Linepharma contributes to training services related to the use of its medicines in developed and developing countries.

 

 

 


'/>"/>
SOURCE WomanCare Global
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WomanCare Global Highlights the Unmet Need of 215 Million Women on Famous CBS Super Screen in Times Square
2. WomanCare Global Acquires 2 Global Brands From ICON -- Combined Oral Contraceptive Roselle® and Emergency Contraceptive Optinor®
3. Perrigo Company to Present at the Leerink Swann 2012 Global Healthcare Conference
4. Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
5. Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
6. CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015
7. Generic Pharmaceuticals Market - A Global Analysis
8. Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
10. MarketsandMarkets: Global In-Vitro Diagnostic (IVD) Market Expected to Reach $64 Billion by 2016
11. Kerry to Expand Center of Excellence with New Cell Science Laboratory Serving Bio-Pharma Customers Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)...  PipelineRx, a leading medication management technology company ... of its SaaS-based telepharmacy platform, PowerGridRx™ , ... Midyear Clinical Meeting and Exhibition, December 5-7 in ... 300 hospital clients nationally, the Company is a ... dramatically improve pharmacy operations, enhance patient safety, and ...
(Date:12/2/2016)... 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today announced ... ("PSI").  The combination of Texas -based Maxor ... PSI bring together both company,s clinical expertise and high-touch patient ... industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... 2, 2016 Lianluo Smart Limited (Nasdaq: ... Company") which develops, markets and sells medical devices ... China and international markets, recently attended ... Treatment New Progress Forum, co-hosted by the Institute ... , Guangdong Provincial People,s Hospital and Cardiology ...
Breaking Medicine Technology:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet ... in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition ... lives. “We are prolonging life 6 years in the last 3 decades,” says ...
(Date:12/2/2016)... ... 02, 2016 , ... Universal Medical Systems, Inc. (UMS) the ... company to offer robotic imaging to veterinary medicine is sponsoring the appearance of ... the American Association of Equine Practitioners 62nd Annual Convention from December 4-6, 2016 ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Yisrayl Hawkins, at ... into how this current generation fits into Bible Prophecy. Yisrayl says this generation, known ... pointing to this conclusion, showing how the details line up exactly with Bible Prophecy ...
Breaking Medicine News(10 mins):